UNIverse - Public Research Portal
Selected Publications
Flury-Sutter, Sarah, Heuzeroth, Frederick, Arbelaez, Emilio, Bubendorf, Lukas, Püschel, Heike, Hayoz, Stefanie, & (2024). Efficacy and tolerability of bacillus Calmette-Guérin strain Russia for the treatment of non-muscle-invasive bladder cancer: Analysis of a prospective registry [Journal-article]. Canadian Urological Association Journal, 18(7). https://doi.org/10.5489/cuaj.8552
Flury-Sutter, Sarah, Heuzeroth, Frederick, Arbelaez, Emilio, Bubendorf, Lukas, Püschel, Heike, Hayoz, Stefanie, & (2024). Efficacy and tolerability of bacillus Calmette-Guérin strain Russia for the treatment of non-muscle-invasive bladder cancer: Analysis of a prospective registry [Journal-article]. Canadian Urological Association Journal, 18(7). https://doi.org/10.5489/cuaj.8552
Wetterauer, Christian, Matthias, Mark, Pueschel, Heike, Deckart, Alexander, Bubendorf, Lukas, Mortezavi, Ashkan, Arbelaez, Emilio, Jean Winkel, David, Heye, Tobias, Boll, Daniel T., Merkle, Elmar, Hayoz, Stefanie, Seifert, Helge H., & (2024). Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING). European Urology Focus, 10(2), 332–338. https://doi.org/10.1016/j.euf.2024.02.006
Wetterauer, Christian, Matthias, Mark, Pueschel, Heike, Deckart, Alexander, Bubendorf, Lukas, Mortezavi, Ashkan, Arbelaez, Emilio, Jean Winkel, David, Heye, Tobias, Boll, Daniel T., Merkle, Elmar, Hayoz, Stefanie, Seifert, Helge H., & (2024). Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING). European Urology Focus, 10(2), 332–338. https://doi.org/10.1016/j.euf.2024.02.006
Garioni, Michele, Tschan, Viviane J., Blukacz, Lauriane, Nuciforo, Sandro, Parmentier, Romuald, Roma, Luca, Coto-Llerena, Mairene, Pueschel, Heike, Piscuoglio, Salvatore, Vlajnic, Tatjana, Stenner, Frank, Seifert, Hans-Helge, , Bubendorf, Lukas, & Le Magnen, Clémentine. (2023). Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer. Npj Precision Oncology, 7. https://doi.org/10.1038/s41698-023-00466-w
Garioni, Michele, Tschan, Viviane J., Blukacz, Lauriane, Nuciforo, Sandro, Parmentier, Romuald, Roma, Luca, Coto-Llerena, Mairene, Pueschel, Heike, Piscuoglio, Salvatore, Vlajnic, Tatjana, Stenner, Frank, Seifert, Hans-Helge, , Bubendorf, Lukas, & Le Magnen, Clémentine. (2023). Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer. Npj Precision Oncology, 7. https://doi.org/10.1038/s41698-023-00466-w
, Thalmann GN, Lucca I, Kwiatkowski M, Wirth GJ, Strebel RT, Engeler D, Pedrazzini A, Hüttenbrink C, Schultze-Seemann W, Torpai R, Bubendorf L, Wicki A, Roth B, Bosshard P, Püschel H, Boll DT, Hefermehl L, Roghmann F, et al. (2022). A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. European Urology Oncology, 5(2), 195–202. https://doi.org/10.1016/j.euo.2021.12.006
, Thalmann GN, Lucca I, Kwiatkowski M, Wirth GJ, Strebel RT, Engeler D, Pedrazzini A, Hüttenbrink C, Schultze-Seemann W, Torpai R, Bubendorf L, Wicki A, Roth B, Bosshard P, Püschel H, Boll DT, Hefermehl L, Roghmann F, et al. (2022). A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. European Urology Oncology, 5(2), 195–202. https://doi.org/10.1016/j.euo.2021.12.006
